3Pharma
ActiveSummary
3Pharma has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€18,557) and a net result of -€3. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 20% of 22,774 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Overview
Official details
Source: KBO- Status
- Active since 28-01-2016 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730and 3 others
- Joint committee
- 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
- Establishment unit
- 2.250.663.482 9100 Sint-Niklaas, since 28-01-2016
- Financial year end
- 31 December
- Peppol
- Reachable since 23-12-2025
Board and ownership
- Minnen-Luyten BVDirector · since 01-08-2017
- Waelput Invest BVDirector · since 01-08-2017
- Waelput Invest50%2025 annual accounts of Waelput Invest
- Holdings
- Shares in 1 company THONICKS
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.1%
- Gross margin
- €84,337
- ▼ 26.4%
- Turnover
- ≈ €410,000
- estimated
- Loss
- €3
- ▼ 99.9%
- Equity
- -€18,557
- =
- Total assets
- €307,833
- ▼ 18.4%
- Employees on 31-12-2025
- 1
- ▼ 50.0%
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityNegative equity -€18,5571 of the last 3 accounts lateSector: Retail trade (NACE 47)lowers riskSize: total assets €307,833Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 17% of them on solvency, 14% on liquidity, 46% on profitability and 38% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 55 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Merger: 3Pharma takes over THONICKSPermanent representatives: MINNEN Tomas and WAELPUT Bart
- · Gazette deed Merger proposal: 3PHARMA BV takes over THONICKS BVRegistered office moved within Sint-Niklaas · New seat: Klein-Hulststraat 14, 9100 Sint-Niklaas · Previous seat: Klapperbeekstraat 36, 9100 Sint-Niklaas
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as 3Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €261,000 and €312,000, founded between 2013 and 2017.
| Company | Total assets | Gross margin |
|---|---|---|
| 3Pharma Sint-Niklaas | €307,833 | €84,337 |
| APOTHEEK BAUWENS Hoegaarden | €311,705 | €89,713 |
| APOTHEEK DE KOCK Antwerpen | €309,622 | €81,850 |
| Apotheek Paricha Zelzate | €260,760 | €86,749 |
| PHARMACIE WILLEMSEN Anderlecht | €307,927 | €86,114 |
| BELAFARM Charleroi | €292,531 | €100,853 |
| PHARMACIE DEBIEVE SYLVIE Honnelles | €273,800 | €81,386 |
Key facts about 3Pharma
- What is the company number of 3Pharma?
- The company number of 3Pharma is 0647.600.506. The VAT number is the same number with BE in front: BE 0647.600.506.
- Where is 3Pharma based?
- The registered office is at Klein-Hulststraat 14, 9100 Sint-Niklaas.Company details
- What does 3Pharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of 3Pharma?
- The legal form of 3Pharma is Private limited company (BV).
- When was 3Pharma founded?
- 3Pharma was founded on 28-01-2016.
- Is 3Pharma still active?
- Yes, 3Pharma is an active enterprise in the KBO register.
- How many employees does 3Pharma have?
- 3Pharma had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does 3Pharma fall under?
- In its 2025 annual accounts, 3Pharma states joint committee 200 (Aanvullend Paritair Comité voor de bedienden).
- What is the turnover of 3Pharma?
- The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €84,337 and 44 comparable companies (NACE 477). It probably lies between €210,000 and €560,000.
- Is 3Pharma profitable?
- In financial year 2025, 3Pharma made a loss of €3.
- Where can I find the annual accounts of 3Pharma?
- 3Pharma filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of 3Pharma due?
- 3Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.